Seeking Alpha·Sep 9, 2026
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health's core sterilization franchise is demonstrating accelerating revenue momentum, with 9.2% year-over-year growth in 2026Q2 and gross margin expansion to 55.4%, reflecting durable pricing power and operating leverage. The company's cash generation r...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 6, 2026 | $0.26+8.8% vs $0.24 | $321M+3.8% vs $310M |
Q2 2026 May 5, 2026 | $0.18+5.9% vs $0.17 | $280M+3.4% vs $271M |
Q1 2026 Feb 24, 2026 | $0.26+8.3% vs $0.24 | $303M+1.3% vs $299M |
Q4 2025 Nov 4, 2025 | $0.26+18.2% vs $0.22 | $311M+3.9% vs $300M |
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Public Employees Retirement System of Ohio purchased a new position in shares of Sotera Health Company (NASDAQ: SHC) during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 81,132 shares of the company's stock, valued at approximately $1,440,000. A number of other
Algert Global LLC lowered its position in Sotera Health Company (NASDAQ: SHC) by 15.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,280 shares of the company's stock after selling 66,610 shares during the period. Algert Global
BlackRock Inc. acquired a new stake in shares of Sotera Health Company (NASDAQ: SHC) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 24,148,424 shares of the company's stock, valued at approximately $428,635,000. BlackRock Inc. owned approximately 8.47% of Sotera
Benchmark SHC against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Sotera Health Company (SHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $18.29 | $5.22B | 67.74 | 5.74% | 6.7% | 15.42% | — | |
| $512.00 | $15.71B | 54.58 | 17.69% | 12.55% | 36.13% | — | |
| $163.90 | $12.55B | 56.52 | -0.37% | 3.99% | 3.54% | — | |
| $277.33 | $13.36B | -95.30 | -0.85% | -5.96% | -7.63% | — | |
| $617.15 | $17.23B | 40.39 | 19.97% | 17.67% | 110.15% | — | |
| $49.33 | $4.08B | 224.23 | -10.86% | -2.42% | -1.59% | — |
Sotera Health Company (SHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Sotera Health Company (SHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 14, 2026·SEC
Aug 6, 2026·SEC
May 22, 2026·SEC
Get notified when SHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Sotera Health Company (SHC) stock FAQ — growth, dividends, profitability & financials explained
Sotera Health Company (SHC) reported $1.22B in revenue for fiscal year 2025. This represents a 63% increase from $746.1M in 2018.
Sotera Health Company (SHC) grew revenue by 5.7% over the past year. This is steady growth.
Yes, Sotera Health Company (SHC) is profitable, generating $163.5M in net income for fiscal year 2025 (6.7% net margin).
Sotera Health Company (SHC) has a return on equity (ROE) of 15.4%. This is reasonable for most industries.
Sotera Health Company (SHC) generated $112.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
